TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
FATE

Fate Therapeutics Inc

Healthcare · Biotechnology

2.50$ +0.4% vs. previous close Closing price · As of: Sep 18, 2026

Investor relations

Report Dates

Investor relations overview for Fate Therapeutics Inc (FATE): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 08/11/2026.

Next report 08/11/2026
Last report 08/13/2026
Earnings surprise by quarter (%)
Q3 23 · 17.9 % 23 Q4 23 · 13.5 % 23 Q1 24 · -4.4 % 24 Q2 24 · 26.7 % 24 Q3 24 · 2.4 % 24 Q4 24 · -3.8 % 24 Q1 25 · 15.8 % 25 Q2 25 · 14.7 % 25 Q3 25 · 3.6 % 25 Q4 25 · 0.0 % 25 Q1 26 · 7.1 % 26 Q2 26 · 10.7 % 26

EPS estimate beaten

Full history 26 of 52 quarters (50%)
Last 16 quarters 13 of 16 quarters (81%)

Earnings Call Transcripts

Search all transcripts →

No transcripts yet — they will show up here automatically after the next earnings call.

News on This Stock

  • 08/13/2026 FATE THERAPEUTICS INC (FATE): Results of Operations and Financial Condition; Financial Statements and Exhibits · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?